共 50 条
- [21] MCTP1 promotes SNAI1-driven neuroendocrine differentiation and epithelial-to-mesenchymal transition of prostate cancer enhancement by ZBTB46/FOXA2/HIF1AEUROPEAN UROLOGY, 2023, 83 : S543 - S543Ho, Y.Liu, Y.Chen, W.Chen, W.Jiang, K.Li, H.Dung, P. V. T.Chen, Z.Hsiao, M.Huang, J.Wen, Y.
- [22] MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate CancerCANCER RESEARCH COMMUNICATIONS, 2024, 4 (09): : 2295 - 2307German, BeatrizAlaiwi, Sarah A.Ho, Kun-LinNanda, Jagpreet S.Fonseca, Marcos A.Burkhart, Deborah L.Sheahan, Anjali V.Bergom, Hannah E.Morel, Katherine L.Beltran, HimishaHwang, Justin H.Freedman, Matthew L.Lawrenson, KateEllis, Leigh
- [23] ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancerCELL REPORTS, 2023, 42 (08):Tabrizian, NakisaNouruzi, ShaghayeghCui, Cassandra JingjingKobelev, MaximNamekawa, TakeshiLodhia, IshanaTalal, AminaSivak, OlenaGanguli, DwaipayanZoubeidi, Amina
- [24] LSD1 regulates the FOXF2-mediated Wnt/β-catenin signaling pathway by interacting with Ku80 to promote colon cancer progressionAMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (08): : 3693 - +Liu, ZhenhuaXiao, JingjingWang, NingDing, Jie
- [25] Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancerONCOGENESIS, 2017, 6 : e288 - e288Ding, J.Xie, M.Lian, Y.Zhu, Y.Peng, P.Wang, J.Wang, L.Wang, K.
- [26] Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancerOncogenesis, 2017, 6 : e288 - e288J DingM XieY LianY ZhuP PengJ WangL WangK Wang
- [27] BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramCLINICAL CANCER RESEARCH, 2021, 27 (17) : 4923 - 4936Kim, Dae-HwanSun, DuanchenStorck, William K.Leng, Katherine WelkerJenkins, ChelseaColeman, Daniel J.Sampson, DavidGuan, XiangnanKumaraswamy, AnbarasuRodansky, Eva S.Urrutia, Joshua A.Schwartzman, Jacob A.Zhang, ChaoBeltran, HimishaLabrecque, Mark P.Morrissey, ColmLucas, Jared M.Coleman, Ilsa M.Nelson, Peter S.Corey, EvaHandelman, Samuel K.Sexton, Jonathan Z.Aggarwal, RahulAbida, WassimFeng, Felix Y.Small, Eric J.Spratt, Daniel E.Bankhead, Armand, IIIRao, ArvindGesner, Emily M.Attwell, SarahLakhotia, SanjayCampeau, EricYates, Joel A.Xia, ZhengAlumkal, Joshi J.
- [28] Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1FRONTIERS IN ONCOLOGY, 2021, 11Xue, PengYan, MiaoWang, KunpengGu, JinbaoZhong, BingTu, Chuanquan
- [29] SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancerSCIENCE, 2017, 355 (6320) : 84 - 88Mu, PingZhang, ZedaBenelli, MatteoKarthaus, Wouter R.Hoover, ElizabethChen, Chi-ChaoWongvipat, JohnKu, Sheng-YuGao, DongCao, ZhenShah, NeelAdams, Elizabeth J.Abida, WassimWatson, Philip A.Prandi, DavideHuang, Chun-Haode Stanchina, ElisaLowe, Scott W.Ellis, LeighBeltran, HimishaRubin, Mark A.Goodrich, David W.Demichelis, FrancescaSawyers, Charles L.
- [30] SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 and RB1 deficient prostate cancerCANCER RESEARCH, 2017, 77Mu, PingZhang, ZedaBenelli, MatteoKarthaus, WouterHoover, ElizebethChen, Chi-ChaoWongvipat, JohnKu, Sheng-YuGao, DongCao, ZhenShah, NeelAdams, ElizabethAbida, WassimWatson, PhilipPrandi, DavideHuang, Chun-Haode Stanchina, ElisaLowe, ScottEllis, LeighBeltran, HimishaRubin, MarkGoodrich, DavidDemichelis, FrancescaSawyers, Charles L.